COVID-19 Research News Update for April 2
Post Date: April 2, 2020 | Publish Date:
The Research Horizons science blog is sharing links to research-oriented news about the COVID-19 pandemic, especially information about how children are affected.
If you see an article that should be shared with the research community, please send a note to scienceblogeditor@cchmc.org
To receive regular email updates about fresh blog posts, use the “sign up” box appearing on any post.
Grand Rounds to focus on COVID-19
Pediatric Grand Rounds, Tuesdays, 8-9 am, will be presented virtually and dedicated to discussions on the current science of COVID-19. A few things to know:
- You do not have to be on-site or connected through Cincinnati Children’s network to participate.
- You can review the planned themes for each session.
- You can submit questions.
- Sessions will be recorded.
- For info: 513-636-6732 or cme@cchmc.org
April 7: Basics: https://cchmcstream.cchmc.org/MediasiteEX/Play/58839237786040dcb14b5b13cc3e9dab1d
April 14: Transmission: https://cchmcstream.cchmc.org/MediasiteEX/Play/0d83de4640a94c6d96f362349d51ea081d
April 21: Personal Protective Equipment: https://cchmcstream.cchmc.org/MediasiteEX/Play/5396ac56111840cea0ead1803ea1166a1d
April 28: Pediatric Disease: https://cchmcstream.cchmc.org/MediasiteEX/Play/3702c22594ad42e1b08032df4d68dc3d1d
Findings Co-Authored by Experts at Cincinnati Children’s
Mayo Clinic Proceedings: Evidence suggests that ACE inhibitors and angiotensin receptor blockers may improve prognosis in COVID-19 hypertensive patients. (https://doi.org/10.1016/j.mayocp.2020.03.026)
Co-author from Cincinnati Children’s: Brandon Henry, MD, Research Fellow, Heart Institute
“In agreement with current guidelines, we recommend patients with hypertension should continue taking anti-hypertensive medications without interruption,” says lead author Fabian Sanchis-Gomar, MD, PhD, of the Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain, and Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Other links to this team’s COVID-19 work:
- Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection
- Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)
- Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections A meta-analysis
- Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19
- Clinical Characteristics of Covid-19 in China
- COVID-19, ECMO, and lymphopenia: a word of caution
EXPLORE THESE SCIENCE UPDATES
NIH Director’s Blog: Bringing Needed Structure to COVID-19 Drug Development
The Lancet: Estimates of the severity of coronavirus disease 2019
The Lancet (accompanying editorial): Likelihood of survival of coronavirus disease 2019
HHS Accelerates Clinical Trials, Prepares for Manufacturing of COVID-19 Vaccines
American Journal of Gastroenterology: Some COVID-19 Patients Present With GI Symptoms Only (pre-proof)
Endocrine Society: Individuals taking class of steroid medications at high risk for COVID-19
Open-Data Repository on Hydroxychloroquine For COVID-19 Prevention and Treatment
The Guardian: Coronavirus vaccine: when will it be ready?
Becker’s Clinical Leadership and Infection Control: US deaths jump 1K in 1 day; 2K+ ventilators in stockpile unavailable — 8 COVID-19 updates
HOW YOU CAN TRACK PEDIATRIC NEWS ABOUT COVID-19
Pandemic tracker from Worldometer
Pandemic tracking dashboard from Johns Hopkins University
Ohio Department of Health: COVID-19 dashboard
Guidance for care providers from Cincinnati Children’s
A frequently updated collection of pediatric COVID-19 papers can be found here
